16 Nov 2021 Research

John Goldman Fellowships for 2022 open in December

Leukaemia UK is delighted to announce that we are funding more ground-breaking research in 2022, by continuing our investment in early career scientists and clinicians for our prestigious John Goldman Fellowships.

Applications for the annual fellowship programme open on 1st December 2021 to scientists and clinician-scientists working in UK universities, research institutions or hospitals. There is no age limit, although the fellowship programme is designed to provide funding at a critical point in a researcher’s career – the transition to becoming an independent researcher.

We have now increased the maximum award available to £150,000, to span a minimum 18-month and maximum 2-year period.

The John Goldman Fellowships were created in honour of Professor John Goldman (1938 – 2013), a renowned haematologist and pioneer in the treatment of leukaemia.

The awards are aimed at early career researchers with a passion for science, a desire to develop new ideas and translate scientific advances into clinical practice.

Successful applicants will show that they are the potential scientific/clinical leaders of the future. Their proposed research project must be novel with the capacity to make advances in our knowledge of leukaemia and related diseases and the development of new and kinder treatments.

Find out more about the 2021 John Goldman Fellows and their research projects:

Dr Daniel Coleman- AML: Developing kinder treatments by targeting mutated RAS

Dr Pramila Krishnamurthy – Understanding how donor lymphocyte infusion can prevent leukaemia patients from relapsing after a stem cell transplant

Dr Samanta Mariani – Investigating the role of macrophages in infant leukaemia

Dr William Grey (pictured above) – Could targeting the repertoire of proteins in AML lead to improved survival for the most at risk patients?

Dr Giulia Orlando (pictured right) – The role of RAS in Juvenile Myelomonocytic Leukaemia-finding new therapies?

Applications for the 2022 fellowships close on 31st January 2022. Find out more about the application process.

Related posts

Myelofibrosis: Finding new ways to treat patients

11 January 2019

Myelofibrosis: Finding new ways to treat patients

Dr Edwin Chen, University of Leeds and John Goldman Fellow

Our life-saving work must continue

4 August 2020

Our life-saving work must continue

Leukaemia and other blood cancers don’t stop for coronavirus (COVID-19) and our vital research and care must continue

An urgent call from One Cancer Voice group of cancer charities for the Comprehensive Spending Review to deliver Government commitments to improve cancer survival & care

10 November 2021

An urgent call from One Cancer Voice group of cancer charities for the Comprehensive Spending Review to deliver Government commitments to improve cancer survival & care

Leukaemia UK has joined with 50 other cancer charities in writing to the Prime Minister, Chancellor of the Exchequer and Secretary of State for Health and Social Care. We are calling on the Government to urgently deliver on commitments to improve cancer survival and care in the forthcoming Spending Review.

“Every little thing is gonna be alright” – three little birds tattoo marks mum’s recovery from one of the least survivable cancers

17 April 2024

“Every little thing is gonna be alright” – three little birds tattoo marks mum’s recovery from one of the least survivable cancers

New research by Leukaemia UK which could reduce the side-effects of treatment for acute myeloid leukaemia (AML) welcomed by family affected by the disease.   A family who was devastated when…